| Therapeutic applications of AS1411 aptamer, an update review R Yazdian-Robati, P Bayat, F Oroojalian, M Zargari, M Ramezani, ... International journal of biological macromolecules 155, 1420-1431, 2020 | 199 | 2020 |
| Aptasensors for quantitative detection of kanamycin RY Robati, A Arab, M Ramezani, FA Langroodi, K Abnous, SM Taghdisi Biosensors and Bioelectronics 82, 162-172, 2016 | 137 | 2016 |
| Recent advances in nanotechnology-based drug delivery systems for the kidney F Oroojalian, F Charbgoo, M Hashemi, A Amani, R Yazdian-Robati, ... Journal of controlled release 321, 442-462, 2020 | 130 | 2020 |
| Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo SM Taghdisi, NM Danesh, M Ramezani, P Lavaee, SH Jalalian, ... European Journal of Pharmaceutics and Biopharmaceutics 102, 152-158, 2016 | 128 | 2016 |
| Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin SA Dorri, H Hosseinzadeh, K Abnous, FV Hasani, RY Robati, BM Razavi Iranian Journal of Basic Medical Sciences 18 (10), 958, 2015 | 82 | 2015 |
| HER2-positive breast cancer immunotherapy: a focus on vaccine development A Arab, R Yazdian-Robati, J Behravan Archivum immunologiae et therapiae Experimentalis 68 (1), 2, 2020 | 74 | 2020 |
| A novel AS1411 aptamer-based three-way junction pocket DNA nanostructure loaded with doxorubicin for targeting cancer cells in vitro and in vivo SM Taghdisi, NM Danesh, M Ramezani, R Yazdian-Robati, K Abnous Molecular pharmaceutics 15 (5), 1972-1978, 2018 | 73 | 2018 |
| Kojic acid–natural product conjugates as mushroom tyrosinase inhibitors M Ashooriha, M Khoshneviszadeh, M Khoshneviszadeh, A Rafiei, ... European Journal of Medicinal Chemistry 201, 112480, 2020 | 65 | 2020 |
| Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs M Hashemi, A Shamshiri, M Saeedi, L Tayebi, R Yazdian-Robati Archives of biochemistry and biophysics 691, 108485, 2020 | 61 | 2020 |
| Aptasensors for quantitative detection of Salmonella Typhimurium N Ansari, R Yazdian-Robati, M Shahdordizadeh, Z Wang, K Ghazvini Analytical biochemistry 533, 18-25, 2017 | 58 | 2017 |
| Acute toxicity of functionalized single wall carbon nanotubes: a biochemical, histopathologic and proteomics approach H Ahmadi, M Ramezani, R Yazdian-Robati, B Behnam, KR Azarkhiavi, ... Chemico-Biological Interactions 275, 196-209, 2017 | 56 | 2017 |
| Proteomics and phosphoproteomics analysis of liver in male rats exposed to bisphenol A: Mechanism of hepatotoxicity and biomarker discovery FV Hassani, K Abnous, S Mehri, A Jafarian, R Birner-Gruenberger, ... Food and Chemical Toxicology 112, 26-38, 2018 | 53 | 2018 |
| Doxorubicin delivery via magnetic nanomicelles comprising from reduction-responsive poly (ethylene glycol)‑b‑poly (ε‑caprolactone)(PEG-SS-PCL) and loaded with superparamagnetic … SD Mousavi, F Maghsoodi, F Panahandeh, R Yazdian-Robati, ... Materials Science and Engineering: C 92, 631-643, 2018 | 47 | 2018 |
| Fluorometric aptasensing of the neonicotinoid insecticide acetamiprid by using multiple complementary strands and gold nanoparticles A Bahreyni, R Yazdian-Robati, M Ramezani, K Abnous, SM Taghdisi Microchimica Acta 185, 1-7, 2018 | 46 | 2018 |
| A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells A Bahreyni, R Yazdian-Robati, S Hashemitabar, M Ramezani, ... International Journal of Pharmaceutics 526 (1-2), 391-399, 2017 | 46 | 2017 |
| Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo R Yazdian-Robati, M Ramezani, SH Jalalian, K Abnous, SM Taghdisi Pharmaceutical research 33, 2289-2297, 2016 | 46 | 2016 |
| Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence P Bayat, M Farshchi, M Yousefian, M Mahmoudi, R Yazdian-Robati International Immunopharmacology, 2021 | 45 | 2021 |
| Application of aptamers in treatment and diagnosis of leukemia R Yazdian-Robati, A Arab, M Ramezani, K Abnous, SM Taghdisi International Journal of Pharmaceutics 529 (1-2), 44-54, 2017 | 44 | 2017 |
| Growth inhibition and apoptosis induction of essential oils and extracts of Nepeta cataria L. on human prostatic and breast cancer cell lines SA Emami, J Asili, S Hossein Nia, R Yazdian-Robati, M Sahranavard, ... Asian Pacific journal of cancer prevention 17 (S3), 125-130, 2016 | 39 | 2016 |
| Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo R Yazdian-Robati, A Arab, M Ramezani, H Rafatpanah, A Bahreyni, ... Drug development and industrial pharmacy 45 (4), 603-610, 2019 | 38 | 2019 |
Khalil AbnousPharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran在 mums.ac.ir 的电子邮件经过验证
